The MedicX Fund Limited Scrip Calculation Price (0287Z)

TIDMMXF

RNS Number : 0287Z

The MedicX Fund Limited

28 August 2018

For immediate release

28 August 2018

MedicX Fund Limited

("MedicX", "the Fund" or "the Company")

Scrip Calculation Price for the September 2018 Dividend in relation to the Scrip Dividend Scheme

On 17 May 2010 the Board of MedicX announced an opportunity for qualifying Shareholders to receive relevant dividends in new Ordinary Shares instead of in cash (the "Scrip Dividend Scheme").

In relation to the dividend for the period 1 April 2018 to 30 June 2018 payable on 28 September 2018 (the "September 2018 Dividend"), the price of a new Ordinary Share in relation to the Scrip Dividend Scheme (the "Scrip Calculation Price") has been set at 80.36 pence. This is the average of the closing middle market quotations for the Company's Ordinary Shares for the five consecutive business days commencing on the ex-dividend date of 16 August 2018.

An online election or Mandate Form must be received by the Company's registrar, Link Asset Services, (or CREST instructions entered) by no later than 5.00 p.m. on 7 September 2018 (the "Mandate Delivery Deadline") in order for elections under the Scrip Dividend Scheme to be effective in relation to the September 2018 Dividend.

On 21 August 2018, the Company published on its website a letter from the Chairman explaining the September 2018 Dividend process and how to elect for the scrip dividend alternative. This letter was also posted to Shareholders new on the Register since 19 May 2018 and before 17 August 2018 (the "Record Date") and Shareholders who had elected to receive hard copy communications. Online elections can be made via www.signalshares.com or a Mandate Form can be obtained from the Company's registrar.

For certificated Shareholders, elections and Mandate Forms remain valid for all Relevant Dividends where a scrip dividend alternative is offered, until cancelled. Therefore, Shareholders who have previously elected online or completed a Mandate Form but no longer wish to receive a scrip dividend should write to Link Asset Services, Corporate Actions, The Registry, 34 Beckenham Road, Beckenham, Kent, BR3 4TU, by no later than 5.00 p.m. on the Mandate Delivery Deadline for the Relevant Dividend to inform them that they wish to revoke the election and receive a cash dividend. In the case of Shareholders who hold their Ordinary Shares in uncertificated form (that is, in CREST), an election via the CREST system must be made each time a Shareholder wishes to receive the scrip dividend alternative.

Shareholders who do not wish to receive a scrip dividend alternative and have not previously completed an online election or a Mandate Form need take no further action and will receive a cash dividend in respect of the September 2018 Dividend in the usual way. The payment date in respect of the September 2018 Dividend is 28 September 2018.

The September 2018 dividend will comprise 50% (0.755p) Property Income Distribution ("PID") and 50% ordinary dividend (0.755p).

Shareholders who have any questions regarding the Scrip Dividend Scheme should contact the Link Asset Services helpline on 0371 664 0321*.

*Calls are charged at the standard geographic rate and will vary by provider. Calls outside the United Kingdom will be charged at the applicable international rate. The helpline is open between 9.00 am - 5.30 pm, Monday to Friday excluding public holidays in England and Wales. Please note that Link Asset Services cannot provide any financial, legal or tax advice and calls may be recorded and monitored for security and training purposes.

End

For further information please contact:

   Octopus Healthcare Adviser Limited                                  [phone] 
   Octopus Healthcare Group                                               [phone] 

Mike Adams, Executive Chairman

   Buchanan                                                                      [phone] 

Charles Ryland/Henry Wilson

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 166 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over GBP1.4 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages GBP8.0 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 220,000 customers.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

MSCSESFEAFASEDA

(END) Dow Jones Newswires

August 28, 2018 08:34 ET (12:34 GMT)